Over the first four years of the Forbes Blockchain 50, the list of billion-dollar companies making meaningful use of the technology popularized by bitcoin, has become a bellwether of institutional adoption.
Drew Weissman and Katalin Kariko, whose work was fundamental in developing the Pfizer/BioNTech and Moderna Covid vaccines, were among the winners of the annual awards given to noteworthy scientists.
Vaccinating the majority of India’s 1.4 billion population in the next few months is going to require more than 2 billion doses. That mind-boggling number has lured a pack of pharma tycoons to jump into the fray to supply them.